M. Kathleen Behrens, Director at IGM Biosciences, Inc. (IGMS), bought 20,000 shares at $25.61 ($497K) on 2019-12-09, disclosed to the SEC on 2019-12-11.
Open-market purchase of $497k IGMS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.26 | 5,497 | $133K | 26.8% |
| 2 | $24.26 | 5,497 | $133K | 26.8% |
| 3 | $25.61 | 4,503 | $115K | 23.2% |
| 4 | $25.61 | 4,503 | $115K | 23.2% |
| Total | $24.87 avg | 20,000 | $497K | 100% |
| Filing → |
| IGMS | BUY | 2022-04-04 | $1.4M | — | Filing → |
| SRPT | SELL | 2021-03-10 | $429K | — | Filing → |
| IGMS | BUY | 2020-12-15 | $3.0M | — | Filing → |